Study targets key molecule to reverse kidney damage in mice
Test likely to proceed to clinical trials BOSTON -- In findings that may lead to clinical trials of a promising new drug for kidney disease, researchers at Beth Israel Deaconess…
My Personal Biomedical Research Feed – Ralph Turchiano, CEO Alchepharma
Test likely to proceed to clinical trials BOSTON -- In findings that may lead to clinical trials of a promising new drug for kidney disease, researchers at Beth Israel Deaconess…
Contact: Bonnie Prescott bprescot@bidmc.harvard.edu 617-667-7306 Beth Israel Deaconess Medical Center BOSTON – A new study led by investigators at Beth Israel Deaconess Medical Center (BIDMC) has shown that a protein…
You must be logged in to post a comment.